04:26 PM EDT, 05/13/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) reported Q1 non-GAAP earnings Tuesday of $0.07 per diluted share, compared with breakeven EPS a year earlier.

One analyst polled by FactSet expected a loss of $0.01.

Net revenue for the quarter ended March 31 was $17.3 million, up from $8 million a year earlier.

Three analysts surveyed by FactSet expected $15.1 million.

The company said that as of March 31, it had cash and cash equivalents of $17.4 million.

Eton shares were rising 2.8% in recent after-hours activity.